Bengaluru-based Healthium Medtech has entered into a definitive agreement to sell its UK-based subsidiary, Clinisupplies to KKR, which is investing through its KKR Health Care Strategic Growth Fund II.

The company will re-invest the proceeds from the transaction to strengthen its portfolio in advanced surgery, wound care, orthopaedics, and post-surgical care through organic and inorganic routes.

Based in Watford, UK, Clinisupplies was acquired by Healthium in 2016. The company has a strong portfolio of products in continence care and partners with the NHS to supply quality and cost-effective continence care products.

The move marks Healthium’s strategic decision to focus on innovation and expansion in areas that the organisation sees as its own core growth areas. Healthium will continue to remain in the UK through its surgical consumables portfolio.

Healthium Medtech has a diverse portfolio of medical devices and consumables, which includes surgical sutures, needles, a patented arthroscopy portfolio, patented wound care portfolio, hernia meshes, haemostats, ligation clips, surgical staplers and other wound closure devices. Currently, the company has eight manufacturing facilities across India, and holds 64 patents across US, Europe and India (including pending applications).